Prognosis

J&J Blood-Clot Pause Done to Educate Doctors, Monitor Cases

Pause could end in ‘a matter of days,’ FDA’s Woodcock says
Officials knew it could cause hit to vaccine confidence

WATCH: U.S. health officials recommended a pause in the use of J&J’s shot on concerns about rare and severe blood clotting side effects.Source: Bloomberg

Have a confidential tip for our reporters? Get in Touch

Before it’s here, it’s on the Bloomberg Terminal

LEARN MORE

By Riley Griffin, John Lauerman, and Angelica Peebles

April 13, 2021 at 7:14 AM EDT

Updated on

April 13, 2021 at 7:04 PM EDT

This article is for subscribers only.

Sign up here for our daily coronavirus newsletter on what you need to know, and subscribe to our Covid-19 podcast for the latest news and analysis.

U.S. health officials urged a pause on the use of Johnson & Johnson’s Covid-19 vaccine due to dangerous blood-clotting to give them time to educate doctors on how to treat the exceedingly rare disorder and to “look in all the nooks and crannies” for other cases.

Have a confidential tip for our reporters? Get in Touch

Before it’s here, it’s on the Bloomberg Terminal

LEARN MORE